Pregled bibliografske jedinice broj: 17584
Intracellular Immunization of Human Immunodeficiency Virus
Intracellular Immunization of Human Immunodeficiency Virus // Periodicum Biologorum / Branko Vitale (ur.).
Zagreb: IGP Štefanović, 1998. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 17584 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Intracellular Immunization of Human Immunodeficiency Virus
Autori
Brdar, Branko ; Matulić, Maja ; Bušić, Milena ; Rubelj, Ivica
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Periodicum Biologorum
/ Branko Vitale - Zagreb : IGP Štefanović, 1998
Skup
First Congress of Croatian Geneticists with International Participation
Mjesto i datum
Hvar, Hrvatska, 01.06.1998. - 04.06.1998
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
HIV; genetic trap; intracellular immunization
Sažetak
There is, at present, no effective anti-HIV treatment available that is specifically and selectively toxic to HIV infected cells. This communication describes an approach to treatment of HIV infection that is based on selective and specific toxicity only to HIV infected cells. Hence, we constructed the replication-defective HIV genomes that are designed to function as rapidly acting genetic traps. These HIV genomes are replication-defective because sequences coding for tat and nef have been deleted and replaced by others coding for diphtheria toxin A fragment (DT-A). When assayed by transfection in cell culture, plasmids carrying the modified HIV genomes completely abort the growth of wild type HIV in susceptible cells (HeLa CD4LTRb-gal). To apply these genetic traps under in vivo conditions, they would need to be presented in the form of HIV virions, capable of specifically and selectively infecting macrophages and T-lymphocytes, the usual targets of HIV infection. Production of such modified virions would, however, require cell lines that are totally resistant to DT-A. We undertook the construction and characterisation of such cell lines, based on engineering resistant forms of DT-A's specific substrate - protein elongation factor EF-2; histidine residue 715 in EF-2 ( that is modified to diphtamide) was replaced by glutamine, methionine, asparagine or leucine which are incapable of serving as substrates for DT-A toxic effects. Cell lines containing such mutated forms of EF-2 show at least ten fold higher resistance to DT-A than the parent cells. Whether or not these cell lines are capable of supporting the multiplication of virions encoding DT-A, remains to be determined.
Izvorni jezik
Engleski
Znanstvena područja
Biologija